Human Laboratory Paradigms Testing ANS-6637
$424,829N01FY2018HDNIH
Yale University, New Haven CT
Investigators
Abstract
The scope of this non-severable Task Order is to test and evaluate in AUD, treatment seeking individuals the efficacy and safety of ANS-6637 in an alcohol cue human laboratory paradigm.
View original record on NIH RePORTER →